Achieving sustained improvement in myocardial perfusion: Role of isosorbide mononitrate

American Journal of Cardiology

Volumn 79, Issue 12 B, 1997, Pages 31-35

  Lewin, Howard C ^a   Berman, Daniel S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGINA PECTORIS AGENT; ISOSORBIDE MONONITRATE;

ANGINA PECTORIS; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART MUSCLE PERFUSION; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANGINA PECTORIS; CORONARY CIRCULATION; HUMANS; ISOSORBIDE DINITRATE; VASODILATOR AGENTS;

EID: 0030848226     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00383-4     Document Type: Conference Paper

References (50)

1. Thadani U. Medical therapy of stable angina pectoris. Cardiol Clin. 9:1991;73-87.
2. Thadani U, Fung H-L, Darke AC, Parker JO. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol. 49:1982;411-419.
3. Acute and long-term antianginal efficacy of continuous twenty-four hour application of transdermal nitroglycerin. Am J Cardiol. 68:91;1263-1273.
4. Fox KM, Dargie HJ, Deanfield J. Avoidance of tolerance and lack of rebound with intermittent dose-titrated transdermal glyceryl trinitrate. Br Heart J. 66:1991;151-155.
5. Thadani U, Maranda CR, Amsterdam E, Spaccavento L, Friedman RG, Chernoff R, Zellner S, Gorwit J, Hinderaker PH. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 120:1994;353-359.
6. DeMots H, Glasser SP. Transdermal-Nitro Trial Study Group. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 13:1989;786-793.
7. Ferratini M, Pierelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable, exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 10:1989;998-1002.
8. Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, Ibrahim R, Watts LE, Garutti RJ, Ferraresi R, Casareto R. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol. 72:1993;1249-1256.
9. Mahmarian JJ, Fenimore NL, Marks GF, Francis MJ, Morales-Ballejo H, Verani MS, Pratt CM. Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography. J Am Coll Cardiol. 24:1994;25-32.
10. Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol. 76:1995;(suppl)122A-125A.
11. Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single-photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol. 15:1990;318-329.
12. Manyari DE, Knudtson M, Kloiber R, Roth D. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation. 77:1988;86-95.
13. Göller V, Clausen M, Henze E, Giesler M, Schmidt A, Kochs M, Hombach V. Reduction of exercise-induced myocardial perfusion defects by isosorbide-5-nitrate: assessment using quantitative Tc-99m-MIBI-SPECT. Coron Artery Dis. 6:1995;245-249.
14. Elhendy A, Geleijnse ML, Roelandt JR, van Domburg RT, Cornel JH, TenCate FJ, Postma-Tjoa J, Reijs AEM, El-Said GM, Fioretti PM. Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol. 76:1995;441-448.
15. Gibbons RJ. Technetium-99m sestamibi in the assessment of myocardial infarction. Semin Nucl Med. 21:1991;213-222.
16. Berman DS, Kiat H, Friedman JD, Wang FP, Van Train K, Matter L, Maddahi J, Germano G. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol. 22:1993;1455-1464.
17. Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Garnett ES. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation. 91:1995;1381-1388.
18. Kiat H, Benari B, Williams C, Wang FP, Van Train K, Areeda J, Germano G, Friedman J, Berman DS. Reproducibility of quantitative rest thallium-201/stress Tc-99m sestamibi dual isotope SPECT for assessment of perfusion defect extent and reversibility. J Nucl Med. 35:1994;103P.
19. Berman DS, Garcia EV, Maddahi J. Thallium-201 myocardial scintigraphy in the detection and evaluation of coronary artery disease. Berman DS, Mason DT. Clinical Nuclear Cardiology. 1981;49-106 Grune & Stratton, New York.
20. Berman DS, Kiat H, Leppo J, Maddahi J. Technetium-99m myocardial perfusion imaging agents. Marcus ML, Schelbert HR, Skorton DJ, Wolf GL. Cardiac Imaging, A Companion to Braunwald's Heart Disease. 1991;1097-1109 WB Saunders, Philadelphia.
21. Maddahi J, Rodrigues E, Berman DS. Assessment of myocardial perfusion by single-photon agents. Pohost G, O'Rourke R. Principles and Practices of Cardiovascular Imaging. 1991;179-219 Little Brown, New York.
22. Berman DS, Kiat H, Friedman JD, Diamond G. Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform. Am J Cardiol. 75:((suppl)):1995;3D-13D.
23. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, German G, Van Train K, Diamond G. Incremental value of prognostic testing in patients with suspected ischemic heart disease: a basis for the optimal utilization of exercise Tc-99m sestamibi myocardial perfusion SPECT. J Am Coll Cardiol. 26:1995;639-647.
24. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 93:1996;905-914.
25. Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O'Connor MK, Mahmarian JJ, Chesebro JH, Wackers FJ. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation. 80:1989;1277-1286.
26. Christian TF, Clements IP, Gibbons RJ. Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m sestamibi. Circulation. 83:1991;1615-1620.
27. Lurie AJ, Salel AF, Berman DS, DeNardo GL, Hurley EJ, Mason DT. Determination of improved myocardial perfusion after aortocoronary bypass surgery by exercise rubidium-81 scintigraphy. Cardiovasc Surg. 54:((suppl 3)):1975;III-20-III-23.
28. Rosing DR, VanRaden MJ, Mincemoyer RM, Bonow RO, Bourassa MG, David PR, Ewels CJ, Detre KM, Kent KM. Exercise, electrocardiographic and functional responses after percutaneous transluminal coronary angioplasty. Am J Cardiol. 53:((suppl)):1984;36C-41C.
29. Scholl JM, Chaitman BR, David PR, Dupras G, Brevers G, Val PG, Crepeau J, Lesperance J, Bourassa MG. Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty. Circulation. 66:1982;380-390.
30. Hirzel HO, Nuesch K, Gruentzig AR, Luetolf UM. Short- and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy. Circulation. 63:1981;1001-1007.
31. Stegaru B, Loose R, Keller H, Buss J, Wetzel E. Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion. Am J Cardiol. 61:((suppl)):1988;74E-77E.
32. Eldridge JE, Burdick DC, Jones RH, Hossack KF. Comparison of nitroglycerin patches and nifedipine. J Cardiovasc Pharmacol. 10:1987;315-319.
33. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol. 77:((suppl)):1996;31C-37C.
34. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation. 73:1986;865-876.
35. Pupita G, Maseri A, Kaski JC, Galassi AR, Gavrielides S, Davies G, Crea F. Myocardial ischemia caused by distal coronary artery constriction in stable angina pectoris. N Engl J Med. 323:1990;514-520.
36. Fujita M, Yamanishi K, Inoko M, Miwa K. Preferential dilation of recipient coronary arteries of the collateral circulation by intracoronary administration of nitroglycerin. J Am Coll Cardiol. 24:1994;631-635.
37. Fujita M, Yamanishi K, Hirai T, Miwa K, Ejiri M, Asanoi H, Sasayama S. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J. 120:1990;521-528.
38. Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single-photon emission computed tomography. Am Heart J. 121:1991;1361-1366.
39. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther. 8:1994;601-610.
40. Thadani U. Nitrate therapy and the development of tolerance. Arch Fam Med. 2:1993;880-885.
41. Parker JO. Update nitrate tolerance. Br J Clin Pharmacol. 34:((suppl)):1992;11S-14S.
42. Abrams J. Nitrate tolerance and dependence. Am Heart J. 99:1980;113-123.
43. Thadani U, Chohan A. Chronic stable angina. Strategies for effective drug therapy. Postgrad Med. 98:1995;175-188.
44. Thadani U, Lipicky RJ. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther. 8:1994;625-633.
45. Thadani U, Lipicky RJ. Short- and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 8:1994;611-623.
46. Parker JO, Amies MH, Hawkinson RW, Heilman JM, Hougham AJ, Vollmer MC, Wilson RR. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Circulation. 91:1995;1368-1374.
47. Lewin HC, Williams C, Tecson J, Hachamovitch R, Berman DS, Kiat H. Sustained quantitative reduction of reversible defect extent by exercise Tc-99m sestamibi/rest thallium-201 myocardial perfusion SPECT with isosorbide mononitrate (IMDUR) (Abstract#31188). Presented at the 69th Scientific Sessions of the American Heart Association; 1996; New Orleans, La.
48. Prigent F, Berman DS, Elashoff J, Rozanski A, Maddahi J, Friedman J, Dwyer J. Reproducibility of stress redistribution thallium-201 SPECT quantitative indices of hypoperfused myocardium secondary to coronary artery disease. Am J Cardiol. 70:1992;1255-1263.
49. Maddahi J, Weiss AT, Garcia EV, Lew AS, Geft I, Swan W, Berman DS. Split-dose thallium-201 quantitative imaging for immediate post-reperfusion assessment of intravenous coronary thrombolysis. Eur Heart J. 6:1985;127-134.
50. Ladenheim M, Pollock BH, Rozanski A, Berman DS, Staniloff HS, Forrester JS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 7:1986;464-471.